Collaborators‎ > ‎

Susan Graham, MD, MPH, PhD, Assistant Professor

Dr. Susan M. Graham received her MPH from Boston University, served for 3 years in the Peace Corps as a Guinea Worm volunteer in Cameroon, and worked for another 3 years at the CDC's Division of Tuberculosis Elimination before
beginning her training in medicine. She trained at McGill University in Montreal, completed internship and residency at the Brigham & Women's Hospital in Boston, then came to the University of Washington for her infectious diseases fellowship. Prior to coming to the University of Washington, Dr. Graham had international research experiences in Cameroon,
Cote d'Ivoire, and Botswana.  Dr. Graham joined the Kenya Research Program in 2003 and has worked in and around Mombasa, Kenya since that time. In 2011, Dr. Graham completed a PhD in Clinical Epidemiology at the University
of Toronto, as part of her K23 career development award on "Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy."

Dr. Graham is currently an Assistant Professor in the departments of Global Health and Medicine at the University of Washington, with an Adjunct Appointment in Epidemiology.  Her research is focused on investigating HIV
and STI transmission among most at-risk populations in Kenya, including female sex workers and men who have sex with men, in collaboration with investigators at the University of Nairobi and the Kenya Medical Research Institute (KEMRI). Currently, Dr. Graham is the PI of a 3-year study entitled "Provider and Peer Support Intervention to Improve ART Adherence among Kenyan Men Who Have Sex with Men."

In addition to her clinical research, Dr. Graham directs the Global Health Pathway for the School of Medicine, teaches medical students in the Global Health Immersion Program, and advises students in the UW's concurrent MD-MPH program. In addition, she is Co-Director for the  annual UW course on "Principles of STD/HIV Research."

Representative Publications

(For a list of full publications please click here and scroll down to the bottom of the page)

  1. Okuku HS, Sanders EJ, Nyiro J, Ngetsa C, Ohuma E, McClelland RS, Price MA, Graham SM. Factors associated with herpes simplex virus type 2 incidence in a cohort of HIV-1-seronegative Kenyan men and women reporting high-risk sexual behavior. Sex Transm Dis. 2011;38:837-844 (PMID 21844740).
  2. Sanders EJ, Wahome E, Mwangome M, Thiong’o AN, Okuku HS, Price MA, Wamuyu L, Macharia M, McClelland RS, Graham SM. Most adults seek urgent healthcare when acquiring HIV-1 and are frequently treated for malaria in coastal Kenya. AIDS. 2011;25:1219-1224 (PMID 21505300).
  3. Graham SM, Krieger JN, Githua PLM, Wamuyu LW, Wale S, Ramko KM, Dragavon JA, Muller CH, Holte SE, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Coombs RW. Post-prostatic massage fluid/urine (post-PMF/U) as an alternative to semen for studying male genitourinary HIV-1 shedding. Sex Transm Infect. 2011;87:232-237 (PMID: 21278399).
  4. Graham SM, Masese L, Gitau R, Richardson BA, Mandaliya K, Peshu N, Jaoko W, Ndinya-Achola J, Overbaugh J, McClelland RS. Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy. Sex Transm Infect. 2011;87:114-117 (PMID 20980464).
  5. Graham SM, Masese L, Gitau R, Jalalian-Lechak Z, Richardson BA, Peshu N, Mandaliya K, Kiarie JN, Jaoko W, Ndinya-Achola J, Overbaugh J, McClelland RS. Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment: a prospective cohort study. J Infect Dis. 2010;202:1538-1542 (PMID 20923373).
  6. Graham SM, Shah PS, Costa-von Aesch Z, Beyene J, Bayoumi AM. A systematic review of the quality of trials evaluating biomedical HIV prevention interventions shows that many lack power. HIV Clinical Trials. 2009;10:413-431 (PMID 20133272).
  7. Graham SM, Masese L, Gitau R, Mwakangalu D, Jaoko W, Ndinya-Achola J, Mandaliya K, Peshu N, Baeten JM, McClelland RS. Increased risk of genital ulcer disease in women during the first month after initiating antiretroviral therapy. JAIDS. 2009;52:600-603 (PMID 19648822).
  8. Graham SM, Holte S, Kimata JT, Wener MH, Overbaugh J. A decrease in albumin in early SIV infection is related to viral pathogenicity. AIDS Res Hum Retroviruses. 2009; 25:433-440 (PMID 19320603).
  9. Graham SM, Baeten JM, Richardson BA, Wener MH, Lavreys L, Mandaliya K, Ndinya-Achola JO, Overbaugh, J, McClelland RS.  A decrease in albumin with HIV-1 acquisition predicts subsequent disease progression. AIDS Res Hum Retroviruses. 2007; 23:1197-1200 (PMID 17961104).
  10. Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS. 2007;21:501-507 (PMID 17301569).